Naturopathic Oncology Research Institute USA
G Mike Makrigiorgos
Dana Farber Cancer Institute-Harvard Medical School USA
Beth Israel Deaconess Medical Center Cancer Center USA
David Geffen School of Medicine-UCLA USA
University of Pisa Italy
Roche Tissue Diagnostics (RTD) USA
University of Pittsburgh School of Medicine USA
Qing Kay Li
The Johns Hopkins Medical Institutions USA
Recommended Global Oncology & Cancer Conferences
Malignancies are an expansive group of infections that include irregular cell development with the possibility to attack or spread to different parts of the body. They shape a subset of neoplasms. A neoplasm or tumor is a gathering of cells that have experienced unregulated development and will frequently shape a mass or irregularity however might be conveyed diffusely. All tumor cells demonstrate the six signs of malignancy. These attributes are required to deliver a harmful tumor. They incorporate.
• Cell development and division truant the best possible signs.
• Continuous development and division even given opposite signs.
• Avoidance of modified cell demise
• Limitless number of cell divisions
• Promoting vein development.
• Invasion of tissue and development of metastases.
The movement from typical cells to cells that can frame a perceptible mass to through and through growth includes numerous means known as threatening movement
A disease in which abnormal cells divide uncontrollably and destroy body tissue.
Most common types:
A cancer that forms in the cells of the breasts.
• Prostate cancer
A cancer in a man's prostate, a small walnut-shaped gland that produces seminal fluid.
• Basal cell cancer
A type of skin cancer that begins in the basal cells.
The most serious type of skin cancer.
• Colon cancer
A cancer of the colon or rectum, located at the lower end of the digestive tract.
A cancer that begins in the lungs and most often occurs in people who smoke.
A cancer of blood-forming tissues, hindering the body's ability to fight infection.
A cancer of the lymphatic system.
Oncogenomics is a sub-field of genomics that characterizes cancer-associated genes. It focuses on genomic, epigenomic and transcript alterations in Cancer. Cancer is a genetic disease caused by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The goal of Oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin and Avastin raised the hope for oncogenomics to elucidate new targets for cancer treatment
Cancer imaging is the procedure and procedure of making visual representations of the inside of a body for clinical investigation and medicinal mediation, and additionally visual representation of the capacity of a few organs or tissues (physiology). Therapeutic imaging tries to uncover inward structures covered up by the skin and bones, and to analyze and treat malady. Restorative imaging likewise builds up a database of typical life structures and physiology to make it conceivable to distinguish variations from the norm. In spite of the fact that imaging of expelled organs and tissues can be performed for medicinal reasons, such strategies are generally considered a portion of pathology rather than therapeutic imaging.
A Cancer marker or tumor marker is a biomarker found in blood, urine, or body tissues that can be hoisted by the nearness of one or more sorts of growth. There are various tumor markers, every demonstrative of a specific illness process, and they are utilized as a part of oncology to distinguish the nearness of malignancy. A hoisted level of a tumor marker can show growth; notwithstanding, there can likewise be different reasons for the height. Tumor markers can be delivered straightforwardly by the tumor or by non-tumor cells as a reaction to the nearness of a tumor.
Disease Chemotherapy and Pharmacology is an associate explored restorative diary covering oncological pharmacotherapy. It was built up in 1978 and is distributed by Springer Science and Business Media. The editors-in-boss are H. Newell (Newcastle University) and E.A. Sausville (University of Maryland). It has been MEDLINE and Pubmed filed since its first issue.
Hematology, likewise spelled hematology, is the branch of pharmaceutical worried with the study, conclusion, treatment, and counteractive action of sicknesses identified with blood. Hematology incorporates the investigation of etiology. It includes treating ailments that influence the generation of blood and its segments, for example, platelets, hemoglobin, blood proteins, bone marrow, platelets, veins, spleen, and the instrument of coagulation. Such maladies may incorporate hemophilia, blood clumps, other draining issue and blood diseases, for example, leukemia, myeloma, and lymphoma. Oncology is a branch of medication that arrangements with the aversion, analysis and treatment of tumor. A therapeutic expert who hones oncology is an oncologist.
Surface epithelial-stromal tumor, otherwise called ovarian epithelial carcinoma, is the most widely recognized kind of ovarian disease, speaking to around 90% of ovarian malignancies. It incorporates serous tumor, endometrioid tumor, and mucinous cystadenocarcinoma. Less basic tumors are threatening Brenner tumor and transitional cell carcinoma of the ovary. Epithelial ovarian tumors create from the epithelium, a layer of cells that covers the ovary.
Renal cell carcinoma is likewise called hypernephroma, renal adenocarcinoma, or renal or kidney growth. It's the most widely recognized sort of kidney tumor found in grown-ups. The kidneys are organs in your body that dispose of waste, while likewise managing liquid adjust. There are small tubes in the kidneys called tubules. It can be defined as a kidney disease that starts in the coating of the proximal convoluted tubule, a part of the little tubes in the kidney that vehicle squander atoms from the blood to the pee. RCC is the most well-known kind of kidney disease in grown-ups, in charge of around 90–95% of cases.
Gynecologic oncology is a specific field of drug that spotlights on malignancies of the female conceptive framework, including ovarian disease, uterine growth, vaginal tumor, cervical disease, and vulvar malignancy. As pros, they have broad preparing in the analysis and treatment of these growths. In the United States, 82,000 ladies are determined to have gynecologic disease annually. In 2013, an expected 91,730 were diagnosed. The Society of Gynecologic Oncology and the European Society of Gynecological Oncology are proficient associations for gynecologic oncologists, and the Gynecologic Oncology Group is an expert association for gynecological oncologists and in addition other restorative experts who manage gynecologic growths. The Foundation for Women's Cancer is the major U.S. association that brings issues to light and research financing and gives instructive projects and materials about gynecologic growths.
Malignancy undifferentiated organisms are disease cells that have attributes connected with ordinary immature microorganisms, particularly the capacity to offer ascent to all cell sorts found in a specific growth test. Cancer Stem Cells are in this way tumorigenic, maybe rather than other non-tumorigenic growth cells. Cancer Stem Cells may create tumors through the undifferentiated organism procedures of self-recharging and separation into numerous cell sorts. Such cells are guessed to hold on in tumors as a particular populace and cause backslide and metastasis by offering ascend to new tumors. Thus, advancement of particular treatments focused at CSCs holds seek after change of survival and personal satisfaction of growth patients, particularly for patients with metastatic illness.
Molecular Cancer is an open get to, companion looked into diary intrigued by pulling in excellent unique research and audits that present or highlight huge advances in every aspect of disease and related biomedical science. Sub-atomic Cancer gives a vital discussion to energizing discoveries in disease related research, exhibiting an unparalleled chance to impart data to masters and general society. Atomic Cancer is occupied with articles from essential, translational and clinical research. Subjects of intrigue incorporate, however are not constrained to: tumor science, angiogenesis, creature models, metastasis, malignancy antigens and the invulnerable reaction to them, cell flagging and sub-atomic science, the study of disease transmission, hereditary and sub-atomic profiling of growth targets, growth undifferentiated organisms, DNA harm and repair, cell cycle, apoptosis, virology and immunization and neutralizer based disease treatments.
In view of inborn confinements in the DNA repair instruments, if people lived sufficiently long, they would all in the long run create cancer. There are no less than 34 Inherited human DNA repair quality changes that expansion malignancy chance. A hefty portion of these changes cause DNA repair to be less compelling than typical. Specifically, Hereditary nonpolyposis colorectal disease (HNPCC) is unequivocally connected with particular transformations in the DNA befuddle repair pathway. BRCA1 and BRCA2, two well known qualities whose changes give a colossally expanded danger of bosom disease on bearers, are both connected with countless repair pathways, particularly NHEJ and homologous recombination.
Immunotherapy is the "treatment of sickness by instigating, improving, or smothering a safe response". Immunotherapies intended to evoke or increase an insusceptible reaction are named actuation immunotherapies, while immunotherapies that decrease or stifle are delegated concealment immunotherapies. Immunomodulatory regimens frequently have less symptoms than existing medications, including less potential for making resistance in microbial disease. Cell-based immunotherapies are compelling for a few diseases. Invulnerable effector cells, for example, lymphocytes, macrophages, dendritic cells, characteristic executioner cells, cytotoxic T lymphocytes, cooperate to shield the body against malignancy by focusing on strange antigens communicated on the surface of tumor cells.
Growth can be dealt with by surgery, chemotherapy, radiation treatment, hormonal treatment, and focused on treatment. The decision of treatment relies on the area and grade of the tumor and the phase of the illness, and additionally the general condition of the patient. Various test tumor medicines are additionally a work in progress. Finish evacuation of the tumor without harm to whatever is left of the body (that is, accomplishing cure with almost zero unfavorable impacts) is the perfect objective of treatment and is frequently the objective by and by. Now and again this can be proficient by surgery, yet the inclination of growths to attack nearby tissue or to spread to inaccessible destinations by minute metastasis frequently restricts its viability; and chemotherapy and radiotherapy can negatively affect ordinary cells. Therefore, cure with not negligible unfavorable impacts might be acknowledged as a commonsense objective now and again; what's more healing aim, viable objectives of treatment can likewise incorporate smothering the malignancy to a subclinical state and keeping up that state for a considerable length of time of good personal satisfaction, and palliative care without therapeutic expectation (for cutting edge arrange metastatic diseases).
There are numerous sorts of tumor treatment. The sorts of treatment that one needs to rely on upon the kind of disease one have and how best in class it is. A few people with tumor will have one and only treatment. Be that as it may, the vast majority have a blend of medicines, for example, surgery with chemotherapy and/or radiation treatment. One may likewise have immunotherapy, focused on treatment, or hormone treatment. Clinical trials may likewise be a possibility for every one of us. Clinical trials are research considers that include individuals. Understanding what they are and how they function can help you choose if partaking in a trial is a decent alternative for every one of us.
Disease screening plans to distinguish malignancy before manifestations show up. This may include blood tests, pee tests, different tests, or restorative imaging. The advantages of screening regarding disease counteractive action, early location and ensuing treatment must be weighed against any harms. Screening can prompt false positive results and consequent intrusive procedures. Screening can likewise prompt false negative results, where a current malignancy is missed. Contention emerges when it is not clear if the advantages of screening exceed the dangers of the screening system itself, and any subsequent indicative tests and medications. Screening tests must be viable, protected, all around endured with acceptably low rates of false positive and false negative results. On the off chance that indications of growth are recognized, more conclusive and obtrusive follow-up tests are performed to achieve a determination. Screening for growth can prompt malignancy aversion and prior determination. Early determination may prompt higher rates of fruitful treatment and developed life. Be that as it may, it might likewise dishonestly seem to build the opportunity to death through lead time inclination or length time predisposition.
Chemotherapy is a class of tumor treatment that utilizations one or more hostile to growth drugs (chemotherapeutic operators) as a major aspect of an institutionalized chemotherapy regimen. Chemotherapy might be given with a therapeutic expectation (which quite often includes blends of medications), or it might plan to drag out life or to lessen side effects (palliative chemotherapy). Chemotherapy is one of the real classifications of therapeutic oncology (the medicinal teach particularly gave to pharmacotherapy for malignancy).
The study of disease transmission is the study and investigation of the examples, causes, and impacts of wellbeing and illness conditions in characterized populaces. It is the foundation of general wellbeing, and shapes arrangement choices and proof based practice by distinguishing hazard components for ailment and focuses for preventive human services. Disease transmission experts help with study outline, accumulation, and measurable investigation of information, change translation and spread of results (counting peer survey and intermittent precise audit). The study of disease transmission has created system utilized as a part of clinical research, general wellbeing thinks about, and, to a lesser degree, fundamental research in the natural sciences
More than 20 tumor sorts are being treated with one or a greater amount of the 70 new disease medicines that have been propelled in the previous five years, with the supported surge in imaginative treatments driving the worldwide oncology market to $107 billion in 2015. In any case, a large portion of these medications are not yet accessible to patients in many nations, and notwithstanding when enrolled they may not be repaid under open protection programs, as indicated by another study discharged today by the IMS Institute for Healthcare Informatics.
The pace of progress in growth care is quickening. A bunch of inventive medications, regularly consolidated with other new or existing pharmaceuticals, and every now and again connected with biomarkers, are rising up out of the innovative work pipeline. Numerous are for tumor sorts connected with low survival rates and where patients have constrained choices. The scene is moving quickly, conveying new intricacy to oncologists, payers and governments who all hope to give proper care to patients while guaranteeing the supportability of medicinal services frameworks. Prior conclusion, longer treatment term and expanded adequacy of medication treatments are adding to rising levels of spending on prescriptions for malignancy mind.
ConferenceSeries Ltd invites all the participants from all over the world to attend 'International Conference on Cancer Biology R&D and Market’ during September 18-19, 2017 in Philadelphia, Pennsylvania, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Cancer cells will be cells that divide constantly, shaping strong tumors or flooding the blood with abnormal cells. Cell division is an ordinary procedure utilized by the body for development and repair. A parent cell partitions to shape two girl cells, and these little girl cells are utilized to assemble new tissue, or to supplant cells that have kicked the bucket accordingly of maturing or harm. Healthy cells quit partitioning when there is no longer a requirement for more little daughter cells, yet growth cells keep on producing duplicates. They are likewise ready to spread starting with one a player in the body then onto the next in a procedure known as metastasis.
Cancer Science-2017 has the stage to satisfy the overarching holes in the change of this exploration of trust, to serve speedily with answers for all in the need. Cancer Science 2017 will have an expected interest of 90+ delegates over the world to talk about the gathering objective.
Why to attend???
Meet Your Target Market With individuals from around the globe concentrated on finding out about most recent developments in screening and medications for disease; this is your single best chance to achieve the biggest collection of members from the Universities, Cancer investigate focuses and healing centers. Lead exhibitions of new screening instruments, disseminate data about novel operators and techniques, meet with very associated speakers, appearing of clinical trials and also progressions in bosom disease treatment, Current strategies and discussions in bosom tumor treatment and get name acknowledgment at this 2-day occasion. Widely acclaimed speakers, the latest systems for screening and in addition for treatment, and the most up to date overhauls in Cancer fields are signs of this meeting.
A Unique Opportunity for Advertisers and Sponsors at this International event: cancerbiology.conferenceseries.com
- Cancer Biologists
- Cancer Stem Cell Specialists
- Presidents & Vice Presidents/ Directors / Administrators
- Business Entrepreneurs
- Medical Devices Companies
- Cancer Associations/ Societies
Cancer 2017 invites participants, moderators, representatives and exhibitors and so on from the globe to Philadelphia, USA. We are pleased to welcome all of you to go to and enroll for the "International Conference on Cancer Biology R&D and Market" which will be held amid September 18-19, 2017 at Philadelphia, Pennsylvania, USA.Whether you are a first clock or a past Cancer Congress member, ConferenceSeries Ltd is get-together of the whole Cancer social order inside the Philadelphia, USA. That offers people an assortment of insightful sessions, workshops et cetera. The coherent program will be a rich mix of plans going from keynote sessions including some prominent and provocative speakers to remarkable and astoundingly instinctive talk sessions. The orchestrating leading body of trustees is get ready up for an initiating and enlightening meeting program and unlimited locations, workshops, symposia on an extent of subjects, distribution presentations and different undertakings for individuals over the globe. We might need to welcome you to Philadelphia, USA at the Cancer 2017 where you'll try to have a significant fitness with specialists from the world. Malady 2017 orchestrating counseling gathering is planning to meet you in Philadelphia, USA.
For more details visit: cancerbiology.conferenceseries.com
Importance and Scope:
The Importance of Cancer 2017 is to redesign, clinically critical gathering of people concerning the confirmation supporting ebb and flow Advances in finding and treatment in the field of Cancer Research. Specialists and researchers over the globe will trade perspectives and ideas. Understudies/Scholars from various colleges assemble and improve their insight. Demonstrative and Pharmaceutical firms will show their novel items and administrations, which permit them to build up their business universally.Cancer 2017 is a universal stage for showing research, exchanging ideas concerning it and along these lines, contributes towards spreading data in research strategies, in analysis and counteractive action of Caner and Related sickness and so forth for the upside of every youthful specialists, Pharmaceutical firms, researchers and the scholarly world. Cancer 2017 is wherever the more drawn out term of show new diagnostics strategies and Instruments utilized for treatment and finding and novel medication. This occasion brings along senior brand advertisers and office administrators to investigate advancing and publicizing openings on Pharmaceutical partnerships.
World Oncology/Cancer Drugs Market estimates to reach $150 billion by 2020, enlisting a CAGR of 7.1% from 2016 to 2020. Late advance in natural treatments has enlarged the size of helpful focuses for treatment of malignancy with the recognizable proof of tumor cell particular qualities. Immunotherapies/biologics are rising as potential treatments to locate the perpetual cure for different growth sorts. Among different biologics, drugs in view of monoclonal antibodies (mAbs) have increased huge consideration lately because of their high adequacy. The disease drugs market is driven by the developing pervasiveness of different sorts of growth, expanding interest of organic and focused on medication treatments, persistent patent expiry of key tumor drugs and the rising effect of biosimilars. Be that as it may, the high cost of medication improvement, the risk of disappointment and the unfriendly impacts of disease medication treatment, especially chemotherapy, ruins the market development. Created countries have executed strict directions for the plan and improvement of growth medications. USFDA and European Union have embraced noteworthy activities to fuel the development of the disease drugs advertise by giving pre-showcase endorsement to potential medications under clinical advancement. Asia-Pacific and LAMEA are promising districts for directing clinical trials due a huge populace base and the minimal effort of clinical trials when contrasted with North America and Europe. By and by, progression of malignancy medication inquire about attributable to organic/focused on treatments and customized meds hold promising open doors for pharmaceutical, bio-pharmaceutical and biotechnology organizations occupied with creating disease drugs.
Philadelphia, Pennsylvania's biggest city, is remarkable for its rich history, in plain view at the Liberty Bell, Independence Hall other American Revolutionary locales. Likewise notorious are the means of the Philadelphia Museum of Art, deified by Sylvester Stallone's triumphant keep running in the film "Rocky." Philadelphia has the third-biggest understudy fixation on the East Coast, with more than 120,000 school and college understudies selected inside the city and about 300,000 in the metropolitan area. There are more than 80 universities, colleges, exchange, and claim to fame schools in the Philadelphia locale. One of the establishing individuals from the Association of American Universities is in city, the University of Pennsylvania, an Ivy League foundation with cases to being the most seasoned college in the country. The city's biggest tuition based school by number of understudies is Temple University, trailed by Drexel University. Along with the University of Pennsylvania, Temple University and Drexel University make up the city's real research colleges. The city is additionally home to five schools of drug: Drexel University College of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia College of Osteopathic Medicine, Temple University School of Medicine, and the Thomas Jefferson University. Clinics, colleges, and advanced education look into establishments in Philadelphia's four congressional locale got more than $252 million in National Institutes of Health concedes in 2015.
Region Wise Scope of Cancer Research in Percentage:
Ø Cancer and Cell Biology
Ø Organ Specific Cancer
Ø Cancer Imaging
Ø Cancer Biomarkers
Ø Cancer Pharmacology
Ø Epithelial Cancer
Ø Renal Cell Cancer
Ø Gynecologic Oncology
Ø Cancer Stem Cells
Ø Molecular Cancer
Ø DNA Repair and Cancer
Ø Cancer Therapy
Ø Cancer Screening
Ø Cancer Epidemiology
Hospitals related to Cancer in Philadelphia:
§ Pennsylvania Hospital
§ Hospital of the University of Pennsylvania
§ Thomas Jefferson University Hospital
§ Albert Einstein Medical Center
§ Magee Rehabilitation Hospital
§ Wills Eye Hospital
§ Abington Memorial Hospital
§ Bryn Mawr Hospital
§ Aria Health
§ Chestnut Hill Hospital
§ Children's Hospital of Philadelphia
Hospitals related to Cancer in USA:
There are 902 Hospitals working on Cancer in USA few of them are listed below:
Ø Memorial Sloan Kettering (MSK) Cancer Center, New York City
Ø University of Texas M.D. Anderson Cancer Center, Houston
Ø Mayo Clinic, Rochester, Minnesota
Ø Dana-Farber/Brigham and Women's Cancer Center, Boston
Ø Johns Hopkins Hospital, Baltimore, Maryland
Ø University of Washington Medical Center, Seattle
Ø Massachusetts General Hospital, Boston
Ø UCSF Medical Center, San Francisco
Ø Stanford Hospital and Clinics, Stanford, California
Ø Hospitals of the University of Pennsylvania–Penn Presbyterian, Philadelphia
Ø City of Hope, Los Angeles
Ø Cleveland Clinic
Ø New York–Presbyterian University Hospital of Columbia and Cornell, New York City
Ø University of Colorado Hospital, Denver
Ø Moffitt Cancer Center, Tampa, Florida
Ø Northwestern Memorial Hospital, Chicago
Ø Seidman Cancer Center at UH Case Medical, Cleveland
Ø Fox Chase Cancer Center, Philadelphia
There are 9368 Hospitals working on Cancer Worldwide few of them are listed below:
Ø University of Texas MD Anderson Cancer Center (Houston)
Ø University of Texas MD Anderson Cancer Center (Houston)
Ø Memorial Sloan-Kettering Cancer Center (New York)
Ø Memorial Sloan-Kettering Cancer Center (New York)
Ø Johns Hopkins Hospital (Baltimore)
Ø Mayo Clinic (Rochester, Minn.)
Ø Dana-Farber/Brigham and Women's Cancer Center (Boston)
Ø Duke University Medical Center (Durham, N.C.)
Ø Seattle Cancer Care Alliance/University of Washington Medical Center (Seattle)
Ø University of Chicago Hospitals
Ø Johns Hopkins Hospital (Baltimore) and UCLA Medical Center (Los Angeles)
Ø Massachusetts General Hospital (Boston)
Ø UCLA Medical Center (Los Angeles)
Ø Massachusetts General Hospital (Boston)
Ø Roswell Park Cancer Institute (Buffalo, N.Y.)
Ø UCSF Medical Center (San Francisco)
Top universities/ College related to Cancer in Philadelphia:
Ø Abramson Family Cancer Research Institute
Ø Wistar Institute: Conejo-Garcia Jose R MD
Ø Fox Chase Cancer Center
Ø Cancer Treatment Centers of America at Eastern Regional Medical Center
Ø Thomas Jefferson University
Ø Abramson Cancer Center Hospital University of Pennsylvania (HUP)
Ø Kimmel Cancer Center
Ø University of Pennsylvania Hematology/Oncology Fellowship
Ø Fels Institute
Ø Abramson Cancer Center: Feldman Arthur M MD
Top universities/ College related to Cancer in USA:
There are about 60 universities/ Colleges working on Cancer in USA few of them are listed below:
Ø Massachusetts Institute of Technology
Ø University of California at Los Angeles
Ø Johns Hopkins University
Ø Texas A & M University
Ø Princeton University
Ø California Institute of Technology – Caltech
Ø Yale University
Ø Cornell University
Ø Georgia University of Technology
Ø Emory University
Ø Stanford University
Ø Northwestern University
Ø University of Miami
Top universities/ College related to Cancer in Worldwide:
There are 2443 universities/ Colleges working on Cancer Worldwide few of them are listed below:
Ø Harvard University
Ø University of Cambridge
Ø University of Oxford
Ø Massachusetts Institute of Technology
Ø Johns Hopkins University
Ø Stanford University
Ø University of California, San Francisco (UCSF)
Ø Yale University
Ø Karolinska Instituet
Ø University of California, Los Angeles (UCLA)
Ø The University of Sydney
Ø The University of Melbourne
Ø King’s College London
Ø University of Michigan
Ø McGill University
Ø The University of Edinburgh
Ø Kyoto University
Ø Hong Kong University of Science and Technology
Ø University of Tsukuba
Major Associations/ Societies related to Cancer
Ø American Cancer Society
Ø Cancer Research Institute
Ø Children’s Cancer research Fund
Ø The Lance Armstrong Foundation
Ø Vietnam Cancer Charities Fund
Ø Cancer Survivor’s Fund
Ø Acoustic Neuroma Association
Ø Acoustic Neuroma Association of Australia
Ø Acoustic Neuroma Association of Canada
Ø American Association for Cancer Research
Ø American Bone Marrow Donor Registry
Ø American Brain Tumor Association
Companies related to Cancer Worldwide:
Ø ABBOTT LABORATORIES
Ø ABBOTT NUTRITION
Ø ABBVIE AND BIOGEN
Ø ACADIA PHARMACEUTICALS
Ø ACORDA THERAPEUTICS
Ø ACTELION PHARMACEUTICALS
Ø ACURA PHARMACEUTICALS
Ø AEGERION PHARMACEUTICALS
Ø AKRIMAX PHARMACEUTICALS
Ø ALCON LABORATORIES
Ø ALEXION PHARMACEUTICALS
Ø AMNEAL PHARMACEUTICALS
Ø AMPHASTAR PHARMACEUTICALS
Ø ANI PHARMACEUTICALS
Ø APTALIS PHARMACEUTICAL TECHNOLOGIES
Ø AQUA PHARMACEUTICALS
Ø ATNAHS PHARMA
Ø AYTU BIOSCIENCE
Past Conference Report
The conference proceedings were carried out through various Keynote-presentations by:
- Dr. Stewart Sell, Wadsworth Center, USA
- Dr. Michael Retsky, Harvard School of Public Health, USA
- Dr. Jimmy T. Efird, Brody School of Medicine, USA
- Dr. Sudhakar Akul Yakkanti, SRI International, USA
- Dr. Sherry A. Bradford, Buffalo School of Medical and Biomedical Sciences, USA
Also, the conference proceeding was encouraged through the wonderful workshop session on “ Animal Models of Cancer Therapy” organized by Dr. Dorothee Herlyn, The Wistar Institute, USA
OMICS Group has taken the privilege of felicitating Cancer Science-2013 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.
The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2013. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group Journal of Cancer Science & Therapy and Journal of Carcinogenesis & Mutagenesis as a special issue. Basing on the conference theme, "Innovations and Novel Therapeutic Strategies in Cancer Science” speakers recommended organizing the conference in the field of Cancer Science and Therapy also in the next year.
We are also obliged to various experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2013. With the unique feedback from the conference, OMICS Group would like to announce the commencement of the "4th World Congress on Cancer Science & Therapy" to be held during October 20-22, 2014 at Chicago, USA.
Past Reports Gallery Cancer Science-2014
OMICS Group’s 4th World Congress on Cancer Science & Therapy was held during October 20-22, 2014 at DoubleTree by Hilton Hotel Chicago - North Shore Conference Center, Chicago, USA.
Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals, scientists, researchers, as well as experts in the cancer research, leaders from the fields of Cancer Therapy, and students from diverse groups, who made this conference one of the most successful and productive events in 2014 from OMICS Group.
The conference proceedings were carried out through effectual keynote lectures by:
Dr. Peter Weightman, University of Liverpool, UK
Dr. Sudhakar Akul Yakkanti, SRI International, USA
Dr. Jeffrey B. Ulmer, Novartis Vaccines & Diagnostics, USA
Dr. Reza Hakkak, University of Arkansas for Medical Sciences, USA
This annual conference brought together eminent experts from different countries in which many modern issues were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided a good platform to share their ideas and experiences in the field of cancer therapy.
The conference was greeted by the welcome message by our moderators Juan Jose Marugan, National Institutes of Health, USA and Bernard Friedenson, University of Illinois, USA, and welcomed Honorable guests Sudhakar Akul Yakkanti, SRI International, USA, Anupam Bishayee, California Northstate University, USA, and Reza Hakkak, University of Arkansas for Medical Sciences, USA.
We sincerely acknowledge all the organizing committee members, moderators, chair and co-chairs, editorial board members, speakers, delegates for their gracious presence, and support in making this event successful. OMICS Group has taken the privilege of felicitating Cancer Science-2014 Organizing Committee Members, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS Group, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.
The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2014. We are glad to inform that all accepted abstracts for the conference have been indexed in OMICS Group Journal of Cancer Science & Therapy and Journal of Carcinogenesis & Mutagenesis as a special issue. Basing on the conference theme, "Enhanced diagnosis, treatment and management of different cancers”, the speakers recommended organizing the conference in the field of Cancer Science and Therapy in the coming years also.
We are obliged to various experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2014. With the unique feedback from the conference, OMICS Group would like to announce its "5th World Congress on Cancer Science & Therapy" to be held during October 20-22, 2014 in Chicago, USA.
Past Reports Gallery Cancer Therapy 2015
OMICS International would like to convey a warm gratitude to all Honorable Guests and Keynote Speakers of Cancer Therapy-2015:
Jack C. Westman, University of Wisconsin School of Medicine, USA
Erwin G. Van Meir, Winship Cancer Institute, USA
Yoshiaki Omura, New York Medical College, USA
Michael Weber, Weber Medical, Germany
Anupam Bishayee, Larkin Health Sciences Institute College of Pharmacy, USA
The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:
A review of cancer immunotherapies and nutritional therapies: Jack C. Westman, University of Wisconsin School of Medicine & Public Health, USA BAI1 is a brain-specific tumor suppressor: Erwin G. Van Meir, Winship Cancer Institute, Emory University, USA
New simple method of detecting various cancers & their biochemical information from rapidly changing part of QRS complex of ECGs and its clinical application for screening and evaluation of cancer: Yoshiaki Omura, New York Medical College, USA
Systemic and interstitial photodynamic laser therapy: New options in oncology: Michael Weber, Weber Medical, Germany
Chemoprevention of experimental mammary carcinoma by Trianthe ma portulacastrum Linn., an Indian dietary and medicinal plant: Anupam Bishayee, Larkin Health Sciences Institute College of Pharmacy, USA
The meeting was executed through various sessions, in which the discussions were held on the following major scientific tracks:
Cancer Cell Biology, Diagnosis and Applied Research
• Organ-Specific Cancer
• Advances in malignancy counteractive action and screening
• Anti-cancer drugs and delivery
• Novel Approaches to Cancer Therapeutics
• Cancer Therapy and Clinical Cancer Research
• Cancer and Lifestyle Connection
• Complementary and Alternative Medicine (CAM)
• Cancer Biomarkers
• Cancer Vaccines
• Cancer Nanotechnology
• Global Cancer Epidemiology
• Cancer Pharmacology
• Cancer Stem Cell Therapy
• Cancer Chemotherapy
• Pediatric Oncology
• Clinical Oncology
• Gastrointestinal Cancer
• Gynecological Cancer
• Radiation Oncology
• Surgical Oncology
• Tumor Virology
• Anti-cancer Agents in Medicinal Chemistry
• Cellular Pathology
• Cancer Metabolomics
• Tumor immunology & immunotherapy
Cancer Therapy 2015 Organizing Committee would like to thank the Moderator of the conference, Sherri Z. Millis from Advanced Individual Medicine, LLC USA who contributed a lot to the smooth functioning of this event.
OMICS International, on behalf of the Cancer Therapy 2015, congratulates the best poster awardee, Sitelbanat Yassin, China Pharmaceutical University, Chinafor her outstanding performance and appreciates all the participants who put their research at poster presentations and sincerely wish them every success in their future endeavors. Also, we would like to thank the poster evaluation committee member Amy McCullough from American Humane Association, USA for his valuable support and advice.
OMICS International is honored to felicitate Cancer Therapy 2015 Organizing Committee and Editorial Board Members of Journal of Cancer Science & Therapy, Journal of Carcinogenesis & Mutagenesis and Journal of Chemotherapy, Keynote Speakers, Chairs & Co-Chairs and also the Moderator of the conference whose support and efforts made the conference to move in the path of success.
Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Cancer Therapy 2015, OMICS International is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, 14th World Congress on Cancer Therapy to be held during June 5th - 7th, 2016 at Philadelphia, USA.
Past Reports Proceedings Gallery
All accepted abstracts will be published in respective Conferenceseries International Journals.
Abstracts will be provided with Digital Object Identifier by